The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoehn, P.
Right arrow Articles by Schmitt, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoehn, P.
Right arrow Articles by Schmitt, E.

The Journal of Immunology, Vol 155, Issue 8 3788-3793, Copyright © 1995 by American Association of Immunologists


ARTICLES

Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains

P Hoehn, S Goedert, T Germann, S Koelsch, S Jin, N Palm, E Ruede and E Schmitt
Institute for Immunology, Johannes Gutenberg University, Mainz, Germany.

The development of naive dense CD4+ T cells from different mouse strains toward Th1 cells, as monitored by measuring secondary IFN-gamma production, was affected by TGF-beta 2 in a differential way. Th1 cell development of naive CD4+ T cells from strains C57Bl/6, BALB/c, and NMRI primed by immobilized anti-CD3 mAb was strongly inhibited in the presence of TGF-beta 2. Even when the Th1 cell-inducer IL-12 was added, the same effect of TGF-beta 2 was observed. In contrast, Th1 development was substantially promoted by TGF-beta 2 with T cells from C3H/He and CBA/J mice. Further analyses using CD4+ T cells from (C57Bl/6xCBA/J)F1 hybrids or DBA/1 mice showed that Th1 development was inhibited by TGF-beta 2 if the T cells were activated by anti-CD3 mAb, but it was enhanced upon costimulation with anti-CD28 mAb. Determination of primary IL-2 production revealed that T cells from (C57Bl/6xCBA/J)F1 and DBA/1 mice produced low amounts of IL-2 following stimulation by anti-CD3 mAb alone and comparatively high amounts after coactivation by anti-CD28 mAb. In the presence of TGF-beta 2, the production of IL-2 was completely suppressed if such T cells were activated solely by anti-CD3 mAb, but it was only partially inhibited after costimulation by anti-CD28 mAb. Furthermore, TGF-beta 2-promoted Th1 development of such T cells was strongly inhibited after neutralization of endogenously produced IL-2 and completely restored by the addition of human IL-2. Thus, our results indicate that the TGF- beta 2-mediated stimulation of Th1 cell development requires the presence of relatively high concentrations of IL-2. Therefore, the opposing effect of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells from different mouse strains appears to be the result of the variable potency of the respective CD4+ T cells to produce IL-2 in the presence of TGF-beta 2.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. E. Ramer, Y. F. Vanloubbeeck, and D. E. Jones
Antigen-Responsive CD4+ T Cells from C3H Mice Chronically Infected with Leishmania amazonensis Are Impaired in the Transition to an Effector Phenotype
Infect. Immun., March 1, 2006; 74(3): 1547 - 1554.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress
Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis
Cancer Res., September 15, 2004; 64(18): 6524 - 6529.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Gorham, J. T. Lin, J. L. Sung, L. A. Rudner, and M. A. French
Genetic Regulation of Autoimmune Disease: BALB/c Background TGF-{{beta}}1-Deficient Mice Develop Necroinflammatory IFN-{{gamma}}-Dependent Hepatitis
J. Immunol., May 15, 2001; 166(10): 6413 - 6422.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Li, C. A. Hunter, and J. P. Farrell
Anti-TGF-{beta} Treatment Promotes Rapid Healing of Leishmania major Infection in Mice by Enhancing In Vivo Nitric Oxide Production
J. Immunol., January 15, 1999; 162(2): 974 - 979.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Lingnau, P. Hoehn, S. Kerdine, S. Koelsch, C. Neudoerfl, N. Palm, E. Ruede, and E. Schmitt
IL-4 in Combination with TGF-{beta} Favors an Alternative Pathway of Th1 Development Independent of IL-12
J. Immunol., November 1, 1998; 161(9): 4709 - 4718.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Gorham, M. L. Guler, D. Fenoglio, U. Gubler, and K. M. Murphy
Low Dose TGF-{beta} Attenuates IL-12 Responsiveness in Murine Th Cells
J. Immunol., August 15, 1998; 161(4): 1664 - 1670.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Seder, T. Marth, M. C. Sieve, W. Strober, J. J. Letterio, A. B. Roberts, and B. Kelsall
Factors Involved in the Differentiation of TGF-{beta}-Producing Cells from Naive CD4+ T Cells: IL-4 and IFN-{gamma} Have Opposing Effects, While TGF-{beta} Positively Regulates Its Own Production
J. Immunol., June 15, 1998; 160(12): 5719 - 5728.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Bohn, E. Schmitt, C. Bielfeldt, A. Noll, R. Schulte, and I. B. Autenrieth
Ambiguous Role of Interleukin-12 in Yersinia enterocolitica Infection in Susceptible and Resistant Mouse Strains
Infect. Immun., May 1, 1998; 66(5): 2213 - 2220.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
I. M. Conboy, R. H. DeKruyff, K. M. Tate, Z. A. Cao, T. A. Moore, D. T. Umetsu, and P. P. Jones
Novel Genetic Regulation of  T Helper 1 (Th1)/Th2 Cytokine Production and Encephalitogenicity in Inbred Mouse Strains
J. Exp. Med., February 3, 1997; 185(3): 439 - 452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.